Metabolic Syndrome, Central Obesity and Insulin Resistance are Associated with Adverse Pathological Features in Postmenopausal Breast Cancer
- 1 May 2010
- journal article
- Published by Elsevier in Clinical Oncology
- Vol. 22 (4) , 281-288
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- An examination of the prevalence of IDF- and ATPIII-defined metabolic syndrome in an Irish screening populationIrish Journal of Medical Science (1971 -), 2009
- Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes FederationDiabetic Medicine, 2006
- Body mass index as a prognostic feature in operable breast cancer: the International Breast Cancer Study Group experienceAnnals of Oncology, 2004
- Body size and breast cancer risk: Findings from the European prospective investigation into cancer and nutrition (EPIC)International Journal of Cancer, 2004
- The Emergence of the Metabolic Syndrome with MenopauseThe Journal of Clinical Endocrinology & Metabolism, 2003
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsNew England Journal of Medicine, 2003
- Body mass and stage of breast cancer at diagnosisInternational Journal of Cancer, 2001
- Anthropometry and Breast CancerThe Journal of Nutrition, 1997
- The Nottingham prognostic index in primary breast cancerBreast Cancer Research and Treatment, 1992
- Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in manDiabetologia, 1985